361 – 370 of 388
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene : Implications for Presymptomatic Testing and Screening
(
- Contribution to journal › Article
- 1994
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
- 1993
-
Mark
An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer
(
- Contribution to journal › Article
- 1992
-
Mark
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
(
- Contribution to journal › Article
-
Mark
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
(
- Contribution to journal › Article
-
Mark
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer
(
- Contribution to journal › Article